{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:24:10Z","timestamp":1790036650243,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jhin.2023.12.012","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T07:24:39Z","timestamp":1705130679000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy"],"prefix":"10.1016","volume":"145","author":[{"given":"E.","family":"Krsakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cermak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fedorko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2023.12.012_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.23937\/2469-5742\/1510079","article-title":"Comparative effectiveness of single-dose of fosfomycin vs. cefoxitin plus ciprofloxacin as a prophylaxis to prevent transrectal prostate biopsy complications","volume":"7","author":"Abascal","year":"2021","journal-title":"Int Arch Urol Complic"},{"key":"10.1016\/j.jhin.2023.12.012_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2019.08.007","article-title":"Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the FUTURE Trial, a multicentre randomised controlled trial","volume":"2","author":"Wegelin","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.jhin.2023.12.012_bib3","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","article-title":"Infectious complications and hospital admissions after prostate biopsy in a European randomized trial","volume":"61","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.jhin.2023.12.012_bib4","first-page":"CD006576","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","volume":"11","author":"Zani","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhin.2023.12.012_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.euf.2016.09.006","article-title":"Trends in antibiotic resistance in urologic practice","volume":"2","author":"Kandil","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.jhin.2023.12.012_bib6","unstructured":"European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/ [last accessed February 2021]."},{"key":"10.1016\/j.jhin.2023.12.012_bib7","series-title":"Presented at the EAU Annual Congress, Milan, 2023","first-page":"234","article-title":"EAU \u2013 EANM \u2013 ESTRO \u2013 ESUR \u2013 ISUP \u2013 SIOG Guidelines on Prostate Cancer","author":"Mottet","year":"2023"},{"key":"10.1016\/j.jhin.2023.12.012_bib8","first-page":"224","article-title":"Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"204","author":"Pilatz","year":"2020","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jhin.2023.12.012_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jhin.2023.12.012_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jhin.2023.12.012_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000296290","article-title":"Is it possible to predict sepsis, the most serious complication in prostate biopsy?","volume":"84","author":"Simsir","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.jhin.2023.12.012_bib12","first-page":"339","article-title":"Jednodenn\u00ed antibakteri\u00e1ln\u00ed profylaxe u biopsie prostaty","volume":"10","author":"Bro\u010f\u00e1k","year":"2009","journal-title":"Urol Praxi"},{"key":"10.1016\/j.jhin.2023.12.012_bib13","first-page":"106","article-title":"Antibiotick\u00e1 profylaxe u transrekt\u00e1ln\u00ed f\u00fazn\u00ed biopsie prostaty","volume":"25","author":"\u0158ez\u00e1\u010d","year":"2021","journal-title":"Ces Urol"},{"key":"10.1016\/j.jhin.2023.12.012_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/antibiotics11030415","article-title":"comparison of fluoroquinolones and other antibiotic prophylaxis regimens for preventing complications in patients undergoing transrectal prostate biopsy","volume":"11","author":"Tulone","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jhin.2023.12.012_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.aju.2016.05.003","article-title":"Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a prospective randomised study","volume":"14","author":"Fahmy","year":"2016","journal-title":"Arab J Urol"},{"key":"10.1016\/j.jhin.2023.12.012_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01877485","article-title":"Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients","volume":"16","author":"Janknegt","year":"1994","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.jhin.2023.12.012_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000355103","article-title":"Fosfomycin trometamol (3,000 mg) in perioperative antibiotic prophylaxis of healthcare-associated infections after endourological interventions: a narrative review","volume":"92","author":"Wagenlehner","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.jhin.2023.12.012_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.prnil.2021.03.001","article-title":"Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora","volume":"9","author":"Lim","year":"2021","journal-title":"Prostate Int"},{"key":"10.1016\/j.jhin.2023.12.012_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/medicina59050911","article-title":"Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: a systematic review and meta-analysis","volume":"59","author":"Gu","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.jhin.2023.12.012_bib20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.euf.2021.11.007","article-title":"Fosfomycin trometamol for the prevention of infectious complications after prostate biopsy: a consensus statement by an international multidisciplinary group","volume":"8","author":"Bjerklund Johansen","year":"2022","journal-title":"Eur Urol Focus"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670124000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:23:46Z","timestamp":1759292626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670124000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":20,"alternative-id":["S0195670124000033"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2023.12.012","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2023.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}